What's black, green, and filled with dragons? The two trailers for Season 2 of "House of the Dragon." But why split sides based on color, and what's the difference between these two trailers, anyway?

New US tax rules restricting foreign-linked entities are dividing the energy tax credit market and complicating investment, ...

Investors with a lot of money to spend have taken a bullish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

On a day when nothing worked for investors, yesterday’s unusual options activity had plenty of variety, especially in the top three. Here’s how investors might have played each of the stock's and ...

Fintel reports that on March 2, 2026, Argus Research upgraded their outlook for Pfizer (NYSE:PFE) from Hold to Buy. As of February 25, 2026, the average one-year price target for Pfizer is ...

Pfizer Inc. (NYSE:PFE) is included among the 14 Best Dividend Stocks to Invest in Under $50. On March 2, Argus upgraded Pfizer Inc. (NYSE:PFE) to Buy from Hold. The firm set a $35 price target on the ...

Besides the stock price changes, a few fundamental catalysts have also emerged. These changes include the operation updates both companies provided in their FQ4 earnings reports (ER) for 2025. In ...

BioNTech (BNTX) stock slides as 2026 revenue outlook misses forecasts and a CEO succession begins. Read more here ...

The stock is down, but the good news is that it sports a fat dividend yield of 6.4%. Pfizer has been struggling lately, but it has a rich pipeline of drugs in development. The pharmaceutical giant ...

Deep-pocketed investors have adopted a bearish approach towards Pfizer (NYSE:PFE), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...